|
39
|
216
|
5vu0A |
Crystal structure of the complex between afucosylated/galactosylated human igg1 fc and fc gamma receptor iiia (cd16a) with man5 n-glycans |
|
34
|
178
|
5v4mA |
Structure of hla-dr15 with bound alpha3(135-145) peptide |
|
46
|
274
|
5werA |
Crystal structure of tapbpr and h2-dd complex |
|
16
|
97
|
5wkgB |
Crystal structure of human cd1b in complex with pa |
|
73
|
273
|
5w67A |
Hla-c*06:02 presenting vrsrr(aba)lrl |
|
43
|
213
|
5w1kC |
Junv gp1 cr1-10 fab cr1-28 fab complex |
|
63
|
273
|
5vgdA |
Crystal structure of hla-c*0501 in complex with sae |
|
27
|
179
|
5v4nA |
Structure of hla-dr1 with bound alpha3(135-145) peptide |
|
13
|
99
|
5wwjB |
Crystal structure of hla-a*2402 in complex with avian influenza a(h7n9) virus-derived peptide h7-25 (data set 1) |
|
14
|
99
|
5wkeB |
Crystal structure of human cd1b in complex with ps |
|
14
|
97
|
5vvpB |
Hla-b*57:03 presenting lsspvtksw |
|
13
|
99
|
5xmfB |
Crystal structure of feline mhc class i for 2,1 angstrom |
|
14
|
99
|
5wmpB |
Crystal structure of hla-b7 in complex with tpr, a cmv peptide |
|
73
|
273
|
5w6aA |
Hla-c*06:02 presenting artelyrsl |
|
79
|
276
|
5vvpA |
Hla-b*57:03 presenting lsspvtksw |
|
14
|
100
|
5vgeB |
Crystal structure of hla-c*07:02 in complex with ryr peptide |
|
13
|
97
|
5u6qF |
Structure of human mr1-3-f-sa in complex with human mait a-f7 tcr |
|
72
|
280
|
5wl1A |
Crystal structure of human cd1b in complex with pg |
|
64
|
275
|
5w1wA |
Structure of the hla-e-vmaprtlvl/gf4 tcr complex |
|
15
|
99
|
5w67B |
Hla-c*06:02 presenting vrsrr(aba)lrl |
|
76
|
276
|
5vufA |
Hla-b*57:01 presenting ltvqvarvy |
|
27
|
218
|
5v4eA |
Engineered human igg fc domain glyco801 (fc801) |
|
14
|
99
|
5wmqB |
Crystal structure of hla-b8 in complex with elr, an influenza a virus peptide |
|
16
|
100
|
5w6aB |
Hla-c*06:02 presenting artelyrsl |
|
38
|
215
|
5v4nC |
Structure of hla-dr1 with bound alpha3(135-145) peptide |
|
14
|
99
|
5cfhA |
Human beta-2 microglobulin double mutant w60g-y63w |
|
14
|
100
|
5ckaA |
Human beta-2 microglobulin double mutant w60g-n83v |
|
14
|
98
|
5f9jB |
Structure of hla-a2:01 with peptide y9l |
|
41
|
212
|
5dmkB |
Crystal structure of iag7 in complex with rlgl-we14 |
|
58
|
263
|
5bxfA |
Apo fcrn structure at ph 4.5 |
|
75
|
281
|
5c9jA |
Human cd1c with ligands in a' and f' channel |
|
15
|
100
|
5c0jB |
Hla-a02 carrying rqfgpdwiva |
|
79
|
277
|
5c0fA |
Hla-a02 carrying rqwgpdpaav |
|
79
|
277
|
5c0eA |
Hla-a02 carrying ylggpdfpti |
|
81
|
277
|
5c0jA |
Hla-a02 carrying rqfgpdwiva |
|
40
|
212
|
5bw7A |
Crystal structure of nonfucosylated fc y296w mutant complexed with bis-glycosylated soluble form of fc gamma receptor iiia |
|
82
|
277
|
5c0iA |
Hal-a02 carrying rqfgpdfpti |
|
14
|
100
|
5c0eB |
Hla-a02 carrying ylggpdfpti |
|
16
|
99
|
5bxfB |
Apo fcrn structure at ph 4.5 |
|
15
|
99
|
5c9jB |
Human cd1c with ligands in a' and f' channel |
|
77
|
276
|
5c0cA |
1e6 tcr in complex with hla-a02 carrying rqfgpdwiva |
|
15
|
100
|
5c0dB |
Hla-a02 carrying aqwgpdpaaa |
|
15
|
100
|
5c0gB |
Hla-a02 carrying ylggpdfpti |
|
15
|
100
|
5c0fB |
Hla-a02 carrying rqwgpdpaav |
|
75
|
275
|
5b39A |
Kir3dl1*015 in complex with hla-b*57:01 |
|
13
|
99
|
5bjtB |
Crystal structure of human fcrn with a peptide inhibitor at multiple sites |
|
71
|
275
|
5b38A |
Kir3dl1*005 in complex with hla-b*57:01 |
|
14
|
100
|
5brzB |
Mage-a3 reactive tcr in complex with mage-a3 in hla-a1 |
|
54
|
263
|
5bjtA |
Crystal structure of human fcrn with a peptide inhibitor at multiple sites |
|
15
|
100
|
5bs0B |
Mage-a3 reactive tcr in complex with titin epitope in hla-a1 |